#214 Responsiveness to roxadustat in non-dialysis chronic kidney disease patients with anemia by baseline iron status: a secondary analysis of the ROXSTAR registry
Sign Up to like & getrecommendations! Published in 2025 at "Nephrology Dialysis Transplantation"
DOI: 10.1093/ndt/gfaf116.0446
Abstract: The ROXSTAR Registry (ChiCTR2100046322) is a phase 4, multicenter study conducted in China to evaluate the long-term safety and effectiveness of a 52-week roxadustat treatment in both dialysis and non-dialysis (ND) chronic kidney disease (CKD)… read more here.
Keywords: non absolute; iron; baseline iron; iron repletion ... See more keywords